Collection of Blood From Patients With Cancer
Recruiting · NCT00034216 · Observational (researchers observe without assigning treatment) · Lead sponsor: National Cancer Institute (NCI)
View the official record on ClinicalTrials.gov →What this trial is about
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment. ...
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible.
- Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol.
- Ability to understand and the willingness to sign a written informed consent document.
- INCLUSION FOR APHERESIS:
- Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference.
- Hemoglobin greater than or equal to 10 mg/dL and platelet count \> 75,000/mm(3)
- Weight greater than 25 kg
- HIV negative
- Prothrombin Time - within normal limits
- Partial Thromboplastin Time - within normal limits
- Medically indicated central line in place or adequate peripheral venous access
Exclusion criteria
- None.
Where it is running
1 location listed across 1 US state.
- National Institutes of Health Clinical Center - Bethesda, Maryland, United States